Dowling & Yahnke’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.76M | Buy |
|
|||||
|
2022
Q2 | $4.39M | Buy |
|
|||||
|
2022
Q1 | $6.51M | Sell |
|
|||||
|
2021
Q4 | $7.51M | Buy |
|
|||||
|
2021
Q3 | $7.63M | Buy |
|
|||||
|
2021
Q2 | $5.95M | Buy |
|
|||||
|
2021
Q1 | $4.72M | Buy |
|
|||||
|
2020
Q4 | $4.85M | Buy |
|
|||||
|
2020
Q3 | $5.41M | Sell |
|
|||||
|
2020
Q2 | $19.1M | Buy |
|
|||||
|
2020
Q1 | $12.5M | Sell |
|
|||||
|
2019
Q4 | $10.7M | Sell |
|
|||||
|
2019
Q3 | $7.67M | Sell |
|
|||||
|
2019
Q2 | $8.08M | Buy |
|
|||||
|
2019
Q1 | $6.31M | Sell |
|
|||||
|
2018
Q4 | $7.19M | Sell |
|
|||||
|
2018
Q3 | $8.29M | Sell |
|
|||||
|
2018
Q2 | $5.97M | Buy |
|
|||||
|
2018
Q1 | $4.34M | Hold |
|
|||||
|
2017
Q4 | $3.36M | Buy |
|
|||||
|
2017
Q3 | $1.15M | Sell |
|
|||||
|
2017
Q2 | $1.72M | Buy |
|
|||||
|
2017
Q1 | $1.58M | Hold |
|
|||||
|
2016
Q4 | $1.12M | Buy |
|
|||||
|
2016
Q3 | $1.33M | Sell |
|
|||||
|
2016
Q2 | $1.48M | Buy |
|
|||||
|
2016
Q1 | $975K | Hold |
|
|||||
|
2015
Q4 | $1.18M | Buy |
|
|||||
|
2015
Q3 | $927K | Sell |
|
|||||
|
2015
Q2 | $1.26M | Buy |
|
|||||
|
2015
Q1 | $582K | Hold |
|
|||||
|
2014
Q4 | $514K | Buy |
|
|||||
|
2014
Q3 | $230K | Hold |
|
|||||
|
2014
Q2 | $229K | Buy |
|
|||||
|
2014
Q1 | $207K | Buy |
|